EssilorLuxottica and Politecnico di Milano launch a partnership for the smart glasses of the future

2 years ago

EssilorLuxottica and Politecnico di Milano launch a partnership for the smart glasses of the future EssilorLuxottica and Politecnico di Milano…

Repligen to Report Second Quarter 2022 Financial Results

2 years ago

Webcast and Conference Call to Be Held Tuesday, August 2, 2022 at 8:30 a.m. EDTWALTHAM, Mass., July 19, 2022 (GLOBE…

Quipt Home Medical to Participate at the 42nd Annual Canaccord Growth Conference on August 8th – 11th

2 years ago

Webcasted Presentation to be Held Thursday August 11thCINCINNATI, July 19, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company” or “Quipt”)…

CorVel Announces Quarterly Earnings Release Webcast

2 years ago

FORT WORTH, Texas, July 19, 2022 (GLOBE NEWSWIRE) -- Event: Quarterly Earnings Release Webcast   Hosts: Michael Combs, President and Chief Executive Officer  Brandon O’Brien,…

Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of Geographic Atrophy (GA)

2 years ago

PDUFA target action date is November 26, 2022FDA has stated that it is not currently planning to hold an advisory…

NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression

2 years ago

Indication demonstrates NeuroStar TMS safety and efficacy in improving anxiety symptoms in depressed patientsMALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE)…

Clene Receives Positive EMA Opinion on Orphan Drug Designation for CNM-Au8® for the Treatment of ALS

2 years ago

SALT LAKE CITY, July 19, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its…

Avadel Pharmaceuticals Announces Tentative Approval of LUMRYZ™ (sodium oxybate) extended-release oral suspension

2 years ago

- Validates the safety profile and clinical efficacy of LUMRYZ - Pursuing strategies to accelerate final approval DUBLIN, Ireland, July…

Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer

2 years ago

BOSTON, July 19, 2022 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives…

Tilray Medical Launches Cannabis Education Platform ‘WeCare-MedicalCannabis’ Across Europe

2 years ago

‘WeCare-MedicalCannabis’ A Comprehensive Resource for Medical Cannabis Education is Now Available in English, German, French, and PortugueseNEUMÜNSTER, Germany, July 19,…